Although the function of RPL39 is unknown in breast cancer, N(G)-methyl-L-arginine acetate, a pan-iNOS inhibitor, decreased breast cancer cell proliferation in in vitro and in vivo mouse models [219]. Here, NOS2 is linked to breast cancer.